Coverage
-
March 12, 2014
The state of New Jersey has joined a $22 million settlement to resolve former Genzyme Corp. employees' False Claims Act allegations in Florida federal court that the company marketed its Seprafilm adhesion barrier for unapproved uses, Acting Attorney General John J. Hoffman said Wednesday.
1 other articles on this case.
View all »